Correction: FDA-Transplant Drug story

AP

Print Article

TRENTON, N.J. (AP) In a story Nov. 8 about a new drug approval, The Associated Press misspelled the drug's name. It is Prevymis, not Prevymix.

A corrected version of the story is below:

FDA OKs drug to block infection after marrow transplant

U.S. regulators approve new drug to prevent life-threatening infections in adults after a bone marrow transplant

BY LINDA A. JOHNSON

AP Medical Writer

TRENTON, N.J. (AP) U.S. regulators have approved the first drug to prevent life-threatening infections in adults after a bone marrow transplant.

The Food and Drug Administration on Wednesday approved sales of Merck and Co.'s Prevymis (PREH'-vih-miss) to prevent infections with cytomegalovirus (sy-toe-MEG'-a-low-vy-rus), a common virus. It doesn't sicken most people, but strikes at least half of transplant patients, who are particularly vulnerable to infection. The virus can damage the eyes, lungs and other organs, trigger pneumonia and even kill.

Kenilworth, New Jersey-based Merck says the drug will cost $195 to $270 per day for 100 days.

Each year, about 8,500 Americans receive transplants of blood-forming cells from bone marrow to treat blood cancers or other blood disorders. Currently, they get antiviral therapy if they develop an infection, rather than a preventive treatment.

___

This story has been corrected to show that the name of the approved drug is Prevymis, not Prevymix.

Print Article

Read More Business

White House open to striking health provision from tax bill

AP

November 20, 2017 at 5:46 am | WASHINGTON (AP) The White House says it's willing to strike a health-care provision from Senate legislation to cut taxes and overhaul the tax code if the provision becomes an impediment to passing ...

Comments

Read More

Hard to believe: Some consumers find free health insurance

AP

November 20, 2017 at 5:00 am | WASHINGTON (AP) Consumers are getting the word that taxpayer-subsidized health plans are widely available for next year for no monthly premium or little cost, and marketing companies say they're st...

Comments

Read More

HARVEY MACKAY: Companies must live by a code

November 19, 2017 at 5:00 am | Coeur d'Alene Press A dejected father confided in his pastor with a problem: His youngster had been caught cheating on a test at school. He was crushed, feeling like he had failed as a father, and was concerned it would...

Comments

Read More

Vine & Olive restaurant opens in Riverstone

November 18, 2017 at 5:00 am | Coeur d'Alene Press A European-influenced small-plate menu, a dynamic wine list focused on Northwest producers and interesting imports, and eight local taps are featured at the Vine & Olive opening today at 2037 N. ...

Comments

Read More

Contact Us

(208) 664-8176
215 N. Second St
Coeur d'Alene, Idaho 83814

©2017 The Coeur d'Alene Press Terms of Use Privacy Policy
X
X